{"id":43250,"date":"2025-10-08T15:46:35","date_gmt":"2025-10-08T14:46:35","guid":{"rendered":"https:\/\/bnssghealthiertogether.org.uk\/?page_id=43250"},"modified":"2025-10-08T15:46:35","modified_gmt":"2025-10-08T14:46:35","slug":"evaluation-of-a-pilot-for-use-of-obesity-medications-outside-hospital-settings","status":"publish","type":"page","link":"https:\/\/bnssghealthiertogether.org.uk\/sq\/integrated-care-board\/research-and-evidence\/our-research-portfolio\/nihr-funded-projects\/evaluation-of-a-pilot-for-use-of-obesity-medications-outside-hospital-settings\/","title":{"rendered":"Vler\u00ebsimi i nj\u00eb projekti pilot p\u00ebr p\u00ebrdorimin e ila\u00e7eve p\u00ebr obezitetin jasht\u00eb ambienteve spitalore"},"content":{"rendered":"
Seksioni me titull module-1<\/span><\/a>
\r\n
\r\n

Vler\u00ebsimi i nj\u00eb projekti pilot p\u00ebr p\u00ebrdorimin e ila\u00e7eve p\u00ebr obezitetin jasht\u00eb ambienteve spitalore<\/strong><\/h1>\n

 <\/p>\n

Financimi<\/h2>\n

Instituti Komb\u00ebtar p\u00ebr K\u00ebrkime n\u00eb Sh\u00ebndet\u00ebsi dhe Kujdes (NIHR) K\u00ebrkime mbi Ofrimin e Kujdesit Sh\u00ebndet\u00ebsor dhe Social Ref NIHR162959.<\/p>\n

Sfondi<\/h2>\n

Medikamentet e reja kund\u00ebr obezitetit, t\u00eb tilla si Tirzepatide (Mounjaro) dhe Semaglutide (Wegovy), ofrojn\u00eb trajtim m\u00eb efektiv kund\u00ebr obezitetit kur kombinohen me nd\u00ebrhyrje n\u00eb sjellje. K\u00ebto medikamente mund t\u00eb p\u00ebrshkruhen brenda sh\u00ebrbimeve t\u00eb specializuara p\u00ebr menaxhimin e pesh\u00ebs (SWMS), t\u00eb cilave u mungon disponueshm\u00ebria n\u00eb t\u00eb gjith\u00eb vendin dhe kapaciteti i mjaftuesh\u00ebm p\u00ebr individ\u00ebt e kualifikuar. Sh\u00ebrbimi Sh\u00ebndet\u00ebsor Komb\u00ebtar i Anglis\u00eb (NHSE) po teston k\u00ebshtu kat\u00ebr modele t\u00eb reja sh\u00ebrbimi p\u00ebr t\u00eb aksesuar medikamentet kund\u00ebr obezitetit n\u00eb kujdesin par\u00ebsor, duke b\u00ebr\u00eb t\u00eb nevojsh\u00ebm nj\u00eb vler\u00ebsim gjith\u00ebp\u00ebrfshir\u00ebs p\u00ebr t\u00eb udh\u00ebhequr zbatimin e tyre n\u00eb t\u00eb ardhmen.<\/p>\n

Synimet<\/h2>\n

1) Vler\u00ebsoni fizibilitetin, pranueshm\u00ebrin\u00eb, sigurin\u00eb, efektivitetin dhe kosto-efektivitetin e modeleve t\u00eb reja p\u00ebr ofrimin e medikamenteve kund\u00ebr obezitetit n\u00eb t\u00eb gjitha grupet socio-demografike,<\/p>\n

2) T\u00eb ofroj\u00eb njohuri p\u00ebr t\u00eb udh\u00ebhequr zbatimin e ardhsh\u00ebm t\u00eb modeleve t\u00eb sh\u00ebrbimit, duke promovuar akses t\u00eb barabart\u00eb n\u00eb ila\u00e7et kund\u00ebr obezitetit.<\/p>\n

Objektivat<\/h2>\n
    \n
  1. Hartoni informacionin kryesor n\u00eb t\u00eb gjitha Bordet e Kujdesit t\u00eb Integruar (BKI), duke p\u00ebrfshir\u00eb llojin\/llojet e modelit t\u00eb sh\u00ebrbimit t\u00eb miratuar dhe karakteristikat kryesore, socio-demografin\u00eb dhe pal\u00ebt e interesuara t\u00eb p\u00ebrfshira.<\/li>\n
  2. Identifikoni faktor\u00ebt socio-demografik\u00eb t\u00eb lidhur me shkall\u00ebt e referimit, marrjeje dhe p\u00ebrfundimit t\u00eb modeleve t\u00eb sh\u00ebrbimit p\u00ebr ila\u00e7et kund\u00ebr obezitetit.<\/li>\n
  3. Vler\u00ebsoni efektivitetin klinik afatshkurt\u00ebr, kosto-efektivitetin dhe sigurin\u00eb n\u00eb t\u00eb gjitha modelet, duke marr\u00eb parasysh ndryshimet socio-demografike.<\/li>\n
  4. Modeloni rezultatet dhe kostot sh\u00ebndet\u00ebsore afatgjata p\u00ebr modele t\u00eb ndryshme sh\u00ebrbimesh.<\/li>\n
  5. Eksploroni potencialin e efektivitetit t\u00eb kostos s\u00eb iniciativave t\u00eb zbatimit p\u00ebr t\u00eb rritur marrjen dhe zbatimin e sh\u00ebrbimeve.<\/li>\n
  6. T\u00eb hetohet fizibiliteti dhe siguria e modeleve t\u00eb reja t\u00eb sh\u00ebrbimit, duke marr\u00eb parasysh nevojat e stafit, trajnimin, ndikimin n\u00eb kujdesin par\u00ebsor dhe implikimet p\u00ebr sistemin m\u00eb t\u00eb gjer\u00eb t\u00eb niveleve t\u00eb menaxhimit t\u00eb pesh\u00ebs.<\/li>\n
  7. Vler\u00ebsoni pranueshm\u00ebrin\u00eb dhe p\u00ebrvoj\u00ebn e p\u00ebrdoruesit t\u00eb modeleve t\u00eb sh\u00ebrbimit, duke p\u00ebrfshir\u00eb komponent\u00ebt e mb\u00ebshtetjes s\u00eb sjelljes, n\u00eb t\u00eb gjitha grupet socio-demografike.<\/li>\n
  8. Zhvilloni njohuri mbi modelet m\u00eb t\u00eb pranueshme, efektive, t\u00eb sigurta dhe me kosto efektive p\u00ebr grupe t\u00eb ndryshme sociodemografike, t\u00eb artikuluara p\u00ebrmes nj\u00eb modeli logjik paraprak.<\/li>\n
  9. Identifikoni nevojat dhe burimet e trajnimit t\u00eb kujdesit par\u00ebsor p\u00ebr zbatimin e tij n\u00eb t\u00eb ardhmen.<\/li>\n
  10. Identifikoni kriteret kryesore p\u00ebr nj\u00eb vler\u00ebsim t\u00eb plot\u00eb t\u00eb fazave t\u00eb m\u00ebtejshme t\u00eb shp\u00ebrndarjes s\u00eb medikamenteve kund\u00ebr obezitetit.<\/li>\n<\/ol>\n

    Metodat, afatet kohore dhe ndikimi dhe p\u00ebrhapja e parashikuar<\/h2>\n

    Projekti do t\u00eb zgjas\u00eb nga shkurti 2025 deri n\u00eb janar 2028. Ai p\u00ebrdor metoda t\u00eb p\u00ebrziera n\u00eb pes\u00eb paketa pune (PP):<\/p>\n

    WP1 (Muajt 1-36, objektivi 1): Menaxhimi i projektit, PPIE, angazhimi i pal\u00ebve t\u00eb interesuara dhe hart\u00ebzimi i informacionit ky\u00e7 rreth modeleve t\u00eb sh\u00ebrbimit ICB p\u00ebr t\u00eb mb\u00ebshtetur WP-t\u00eb pasuese.<\/p>\n

    WP2 (Muajt 6-33, objektivat 2-5): Identifikoni faktor\u00ebt socio-demografik\u00eb q\u00eb lidhen me shfryt\u00ebzimin e sh\u00ebrbimit. Vler\u00ebsoni klinik\u00ebn dhe efektivitetin e kostos, si dhe sigurin\u00eb n\u00eb t\u00eb gjitha modelet dhe grupet socio-demografike duke p\u00ebrdorur nj\u00eb korniz\u00eb studimi t\u00eb synuar. Mbledhja e t\u00eb dh\u00ebnave p\u00ebrfshin t\u00eb dh\u00ebna elektronike sh\u00ebndet\u00ebsore dhe anketa me njer\u00ebz q\u00eb jetojn\u00eb me obezitet (PLWO), ofrues t\u00eb sh\u00ebrbimeve dhe komisioner\u00eb.<\/p>\n

    WP3 (Muajt 6-30, objektivat 6, 7): P\u00ebrdorni metoda cil\u00ebsore n\u00eb kat\u00ebr vende studimi rastesh (q\u00eb p\u00ebrfaq\u00ebsojn\u00eb secilin model sh\u00ebrbimi) p\u00ebr t\u00eb vler\u00ebsuar fizibilitetin, pranueshm\u00ebrin\u00eb, sigurin\u00eb dhe faktor\u00ebt e ndryshimit t\u00eb sjelljes n\u00eb grupe t\u00eb ndryshme socio-demografike. Mb\u00ebshtetur nga nj\u00eb model 'hulumtues rezident' dhe studiues t\u00eb komunitetit PPIE.<\/p>\n

    PP4 (Muajt 6-36, objektivi 8): Integroni t\u00eb dh\u00ebnat n\u00eb t\u00eb gjitha PP-t\u00eb 2 dhe 3 me analiz\u00eb t\u00eb metodave t\u00eb p\u00ebrziera. P\u00ebrdorni nj\u00eb protokoll triangulimi me pal\u00ebt kryesore t\u00eb interesuara p\u00ebr t\u00eb informuar nj\u00eb sh\u00ebrbim t\u00eb hart\u00ebzimit t\u00eb modelit logjik, v\u00ebnien n\u00eb pun\u00eb dhe konfigurimin e tij sipas rezultateve t\u00eb pacient\u00ebve.<\/p>\n

    WP5 (Muajt 1-36, objektivat 9, 10): Shp\u00ebrndarja, rezultatet dhe ndikimi i parashikuar. Informimi i NHSE-s\u00eb p\u00ebr t\u00eb udh\u00ebhequr fazat e m\u00ebtejshme t\u00eb zbatimit dhe vler\u00ebsimit t\u00eb ardhsh\u00ebm, duke theksuar aksesin n\u00eb t\u00eb gjitha grupet socio-demografike.<\/p>\n

    Kush po e udh\u00ebheq hulumtimin?<\/h2>\n

    Dr. Karen Coulman, Profesoresh\u00eb e Asociuar n\u00eb K\u00ebrkimin dhe Praktik\u00ebn e Obezitetit, Shkolla Mjek\u00ebsore e Bristolit (PHS), Universiteti i Bristolit.<\/p>\n

    Informacion i m\u00ebtejsh\u00ebm<\/h2>\n

    Email CI: Karen.Coulman@bristol.ac.uk<\/p>\n

    P\u00ebr m\u00eb shum\u00eb informacion ose p\u00ebr t'u p\u00ebrfshir\u00eb n\u00eb k\u00ebt\u00eb projekt, ju lutemi t\u00eb kontaktoni\u00a0bnssg.research@nhs.net<\/a>.<\/p>\n

    Pik\u00ebpamjet e shprehura jan\u00eb ato t\u00eb autorit\/autor\u00ebve dhe jo domosdoshm\u00ebrisht ato t\u00eb NIHR ose t\u00eb Departamentit t\u00eb Sh\u00ebndet\u00ebsis\u00eb dhe Kujdesit Social<\/p>\n

    Ju lutemi gjeni m\u00eb shum\u00eb informacion k\u00ebtu<\/a>.<\/p>\n <\/div>\r\n <\/section><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

    Vler\u00ebsimi i nj\u00eb projekti pilot p\u00ebr p\u00ebrdorimin e ila\u00e7eve p\u00ebr obezitetin jasht\u00eb ambienteve spitalore<\/p>","protected":false},"author":16,"featured_media":0,"parent":32881,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-43250","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/43250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/comments?post=43250"}],"version-history":[{"count":2,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/43250\/revisions"}],"predecessor-version":[{"id":43252,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/43250\/revisions\/43252"}],"up":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/32881"}],"wp:attachment":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/media?parent=43250"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/tags?post=43250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}